1. Home
  2. LCNB vs EBS Comparison

LCNB vs EBS Comparison

Compare LCNB & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LCNB Corporation

LCNB

LCNB Corporation

SELL

Current Price

$19.14

Market Cap

281.1M

Sector

Finance

ML Signal

SELL

Logo Emergent Biosolutions Inc.

EBS

Emergent Biosolutions Inc.

SELL

Current Price

$5.05

Market Cap

303.3M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
LCNB
EBS
Founded
1877
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
281.1M
303.3M
IPO Year
1999
2006

Fundamental Metrics

Financial Performance
Metric
LCNB
EBS
Price
$19.14
$5.05
Analyst Decision
Hold
Buy
Analyst Count
3
3
Target Price
★ $20.83
$10.00
AVG Volume (30 Days)
16.2K
★ 946.0K
Earning Date
10-15-2026
11-02-2026
Dividend Yield
★ 4.81%
N/A
EPS Growth
68.04
★ 125.83
EPS
★ 1.35
N/A
Revenue
$6,445,000.00
★ $742,900,000.00
Revenue This Year
$11.08
N/A
Revenue Next Year
$0.51
$7.03
P/E Ratio
$14.18
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$14.83
$4.36
52 Week High
$21.32
$14.06

Technical Indicators

Market Signals
Indicator
LCNB
EBS
Relative Strength Index (RSI) 44.26 28.74
Support Level $18.33 $4.36
Resistance Level $19.35 $7.18
Average True Range (ATR) 0.40 0.44
MACD -0.08 -0.09
Stochastic Oscillator 7.28 5.88

Price Performance

Historical Comparison
LCNB
EBS

About LCNB LCNB Corporation

LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections, and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.

Share on Social Networks: